Opus Genetics closes $20M public stock/warrant offering; CEO & chairman buy $1.5M unit

Opus Genetics, Inc.

Public offering of 12,219,736 units (share + warrant) at $0.95/unit plus 8,832,895 pre-funded warrants at $0.9499; gross proceeds ~$20M.
Private placement: 1,176,471 shares and warrants at $1.275/unit to CEO Dr. George Magrath and chairman Cam Gallagher.
Public warrants exercisable at $0.95, private at $1.15; both 5-year terms, callable after OPGx-BEST1 Cohort 1 data and VWAP conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.